Medicinal Cannabis: Integrating science, saftey and balance with Dr Michelle Woolhouse and Dr Nic Giummarra
FX Medicine Podcast CentralShow Notes
In this episode of podcast, Dr Michelle Woolhouse is joined by integrative GP Dr Nic Giummarra to explore the evolving science and clinical application of medicinal cannabis in Australia. From cannabinoid pharmacology and terpene profiles to chemovars and prescribing strategies, Dr Giummarra offers deep insights into how cannabis-based medicines can support patients with chronic pain, inflammation, anxiety, and insomnia.
He explains the distinct roles of phytocannabinoids cannabinol (CBD) and tetrahydrocannabinol (THC), how medicinal cannabis influences sleep, neuroplasticity and emotional regulation, and why the endocannabinoid system is so crucial - yet often overlooked - in conventional care. Dr Giummarra also unpacks the risks of closed-loop prescribing models and "tick-box" clinics, calling for more ethical, patient-centred approaches grounded in evidence, education and practitioner discernment.
This is essential listening for healthcare professionals looking to engage with medicinal cannabis safely, effectively, and responsibly in clinical practice.
Covered in this episode:
(01:02) Welcome Nic Guimmarra
(02:56) History of marijuana
(07:36) The innate cannabinoid system
(10:17) Key chemicals
(13:35) Approved conditions for use
(18:19) Neuroplastic changes
(25:15) Latest research
(30:33) Accessibility options
(38:00) How is it best used?
(47:32) Side effects and interactions
(51:41) Driving and workplace safety rules
(57:57) Future of medicinal cannabis
(1:04:24) Final remarks
Find today's transcript and show notes here: https://www.bioceuticals.com.au/education/podcasts/medicinal-cannabis-integrating-science-saftey-and-balance
Sign up for our monthly newsletter for the latest exclusive clinical tools, articles, and infographics: www.bioceuticals.com.au/signup/
FX DISCLAIMER: The information provided on fx Medicine by BioCeuticals is for educational and informational purposes only. The information provided is not, nor is it intended to be, a substitute for professional advice or care. Please seek the advice of a qualified health care professional in the event something you learn here raises questions or concerns regarding your health.
More from FX Medicine Podcast Central
In this podcast episode, Emma Sutherland speaks with Dr Nick Fuller, Clinical Trials Director at the Royal Prince Alfred Hospital Endocrinology Department and researcher at the Charles Perkins Centre. Together they unpack the complex physiology behind weight regain, including metabolic adaptation, appetite-hormone shifts, and the evolutionary mechanisms that make long-term weight loss so challenging.
Dr Stacy Sims, expert in female physiology and training, collaborates with fx Ambassador Lisa Costa-Bir to discuss the intricate relationship between hormones and physical performance.
Jane Hutchens, naturopath and reproductive health and human genetics expert, along with fx Medicine ambassador, Emma Sutherland, raise awareness on the importance of understanding cardiovascular health implications during pregnancy and post-partum. This impacts 1 to 4 percent of women in Australia and is under recognized and underreported.
In part two of our Perspectives podcast, fx Medicine by BioCeuticals ambassadors Lisa Costa-Bir, Dr Michelle Woolhouse, Mick Alexander and Dr Adrian Lopresti, join host Emma Sutherland to explore practical, evidence-aligned treatment strategies for patients with cardiometabolic dysfunction. The discussion covers GLP-1 receptor agonists (GLP-1 RAs) including side effect management and dietary and lifestyle support. They also discuss the evolving landscape of new cardiometabolic medications, and the behavioural, psychological, and social factors that shape long-term cardiometabolic outcomes.
In this insightful conversation, naturopathic doctor and bestselling author Lara Briden joins Emma Sutherland to explore androgen physiology, excess, and sensitivity in women. Together they discuss the complexities of diagnosing androgen excess, including polycystic ovarian syndrome (PCOS) and adrenal-driven cases, and examine the metabolic consequences of chronically elevated androgens. They discuss the challenging clinical presentation of female pattern hair loss or androgenic hair loss talking about cause and realistic treatments.